P2Y1 antagonist 2
P2Y1 antagonist 2 (Compound 19) is a P2Y1 receptor antagonist (IC50: 0.49 μM) . P2Y1 antagonist 2 has significant antiplatelet aggregation activity and exerts its effects by inhibiting P2Y1 receptor. P2Y1 antagonist 2 can upregulate nuclear Nrf2 protein levels, exhibit neuroprotective effects, and resist oxidative stress damage. P2Y1 antagonist 2 can effectively reduce cerebral infarction area and improve neurobehavioral function, and can be used in the study of ischemic stroke[1].
Product Specifications
UNSPSC
12352005
Target
P2Y Receptor
Related Pathways
GPCR/G Protein
Field of Research
Cardiovascular Disease
Smiles
NC1=NC(CON2C(C(O)=O)=C(N=C2C3=CC(C#N)=CC=C3)C(F)F)=CS1
Molecular Formula
C16H11F2N5O3S
Molecular Weight
391.35
References & Citations
[1]Zhang B, et al. Design, Synthesis, and Biological Evaluation of 4- (Difluoromethyl) -1H-imidazole-5-carboxylic Acids/4- (3-Cyanophenoxy) pyrimidine-5-carboxylic Acids as P2Y1 Receptor Antagonists for Ischemic Stroke Treatment. J Med Chem. 2025 Jun 12;68 (11) :10930-10952.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
A01311-2-PE 100 µg/Vial
Anti-L17A Receptor/IL17RA Antibody Picoband® (PE Conjugate)
Sign In for Pricing
View Details 